explore -WSS

explore

author：comprehensive 2025-09-30 06:09:30 - browse：475

Sterile capsules for injection line up in a dispensing line — politics coverage from STAT — Adobe

WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs.

Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists. Shortages are primarily a problem for hospitals and doctors who regularly administer drugs, including oncologists who have been running out of common chemo drugs. Generic injectables account for 67% of shortages, and more than half of drugs in short supply cost less than $1 per unit, according to the Finance Committee.

Hospitals band together to negotiate drug prices by hiring group purchasing organizations. The biggest three GPOs are estimated to control about 90% of the market for drugs that hospitals buy. Finance Chair Ron Wyden (D-Ore.) said those GPOs can drive prices down so low that manufacturers stop making certain drugs or can’t afford to maintain their facilities, which then leads to manufacturing interruptions. Drugmakers also say GPOs can also be fickle, switching from one manufacturer to another over small savings, leaving drugmakers without the certainty they need to commit to making large volumes of product.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： JPM 2024: Nvidia claims we're in biological revolution. Are we?

WSS

Three issues to watch in global health in 2024

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Biotech reporter’s notebook: A sunnier mood at JPM 2024

New safety details link Apellis eye drug to rare cases of blindness

The SUPPORT Act is critical to fighting the opioid crisis

leisure time

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Cancer drug shortages should be causing more outrage

Health and fitness trackers are measuring the wrong things

BioMarin wins approval for gene therapy to treat hemophilia A

Health and fitness trackers are measuring the wrong things

Malaria cases in Florida and Texas: Here’s what you need to know

Three issues to watch in global health in 2024

Medical records are filled with copy

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

focus

Scientists inch closer to single

Doulas covered by Medicaid under New York's new plan

Mega Millions pot grows to $1.25 billion after no winner

Mitch McConnell episode has important public health takeaway

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

New England Journal of Medicine addresses racist history, slavery

entertainment

entertainment

leisure time

hotspot